Although HMGA2 is known as a critical transcriptional factor regulating EMT in cancers, its role in RPE cells undergoing EMT has not been elucidated thus far (Liang et al., 2014; Zhu et al., 2019; Song et al., 2021; Wang et al., 2021). Here, HMGA2 is linked to cancer.